Lon­za en­ters the ex­o­some ther­a­py space with ac­qui­si­tion of still-new Co­di­ak site

In an­tic­i­pa­tion of tack­ling the man­u­fac­tur­ing prob­lems that come with ex­o­some ther­a­peu­tics head on, Co­di­ak Bio­Sciences built a 12,000-square-foot man­u­fac­tur­ing site in Lex­ing­ton, MA. Tues­day, it an­nounced that it will hand over the reins to a pow­er­house CD­MO.

Swiss man­u­fac­tur­er Lon­za will ac­quire IP rights and the fa­cil­i­ty from Co­di­ak in ex­change for $65 mil­lion worth of man­u­fac­tur­ing ser­vices, the com­pa­nies said.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.